The statute itself is silent on what constitutes essentially copies of a commercially available drug product, but the FDA has interpretated the term broadly
Winzell MS, Ahrn B
February 3, 2025: More Than 100 New Lawsuits Join Litigation Against Ozempic and Other GLP-1 Drugs As of February 3, 1,443 people have joined the multidistrict litigation (MDL) against Ozempics maker (Novo Nordisk) and other GLP-1 manufacturers
324 This process is mediated by the release of various factors, including DAMPs 325 and chemokines such as CXCL10
Previous reviews of clinical trials, animal models, and in vitro studies suggest that dietary vitamins and minerals may contribute to the prevention and treatment of a variety of cancers such as those affecting the breast, lungs, liver, cervix, stomach, brain (glioma), lymphatic system (lymphoma), and prostate (1426)